Gland Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing typically related to share dematerialization or depository-related confirmations. No financial figures, order wins, or business updates have been disclosed in this filing. The submission appears to be a procedural regulatory requirement rather than a material corporate action.
This is a routine regulatory disclosure with no direct impact on the stock price, business operations, or shareholder value. Retail investors need not take any action.